Clinical Trial Update: DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for DaZhu Rhodiola Rosea Capsule in coronary artery disease with angina pectoris is reported, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease

Drugs mentioned

• DaZhu Rhodiola Rosea Capsule

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN